US 8022175
Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases viruses from vaccine strains of Newcastle disease virus
granted A61PA61P37/00
Quick answer
US patent 8022175 (Production of anti-peptide monoclonal antibodies to distinguish Exotic New Castle diseases viruses from vaccine strains of Newcastle disease virus) held by The United States of America, as represented by the Secretary of Agriculture expires Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The United States of America, as represented by the Secretary of Agriculture
- Grant date
- Tue Sep 20 2011 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 15 2031 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61P, A61P37/00